Self-association of simvastatin, which is widely used to treat coronary heart disease, was investigated using electrospray-ionization mass spectrometry. Formation of simvastatin self-associates in various solvents was demonstrated using mass spectrometry. Solvation effects were shown to play a special role in the formation of the self-associates. Self-associates containing from two to fi ve simvastatin molecules were detected in mass spectra of an aqueous MeOH (20%) solution of simvastatin. The formation of simvastatin self-associates could compete with the complexation of supramolecular structures during the synthesis of new generation drugs.Introduction. Electrospray-ionization mass spectrometry (ESI-MS) is a modern method for studying the structures of drugs and supramolecular complexes based on them that are used for targeted delivery and increased bioavailability. The mild ionization conditions of ESI-MS provide advantages over other methods for determining the qualitative and quantitative composition of supramolecular complexes [1, 2]. ESI-MS can be used not only to elucidate the structures of the complexes but also to study the mechanisms of intermolecular interactions because ions are generated directly from solution with retention of the complex structure under electrospray-ionization conditions [1,2]. These features of ESI-MS make it possible to study the binding and dissociation of ligand-receptor complexes [3,4], which enables methods for controlling drugs to be developed and possible side effects to be minimized. Knowledge of the correlations among the intermolecular-interaction mechanisms and the therapeutic effects of drugs on the molecular level provides a fundamental basis for developing new drugs.Herein, simvastatin {1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl-2,2-dimethylbutanoate, C 25 H 38 O 5 , MW = 418.57}, which is widely used to treat coronary heart disease [5], was selected for the ESI-MS studies: